ArticleBMC geriatrics2024
Development and validation of the sarcopenia disease risk perception scale for older adults.
Article in BMC geriatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Validation and cross-cultural adaptation of the Sarcopenia Disease Risk Perception Scale among Turkish older adults.Turkish journal of physical medicine and rehabilitation · 2026Article
- Translation, reliability, and validity of the chinese face-to-face cooperation evaluation scale short version (FACES) in community health and long-term care providers.BMC geriatrics · 2026Article
- Development, Reliability, and Validity of the Treatment Decision-Making Needs Assessment Scale for Chinese Cancer Patients.Patient preference and adherence · 2026Article
- Associations between fear of medical imaging radiation, risk perception, and patient decisional conflict: evidence from variable-centered and person-centered analyses.Frontiers in psychiatry · 2026Article
- Development and psychometric evaluation of the sarcopenia prevention behavior adherence scale for older adults - a mixed methods study.BMC geriatrics · 2025Article
- Development and validation of a risk perception scale on acute respiratory infections for caregivers in long-term care facilities.Frontiers in public health · 2025Article
- Predicting sarcopenia risk in stroke patients: a comprehensive nomogram incorporating demographic, anthropometric, and biochemical indicators.Frontiers in neurology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSarcopenia represents a constant threat to the health of older adults, and accurate risk perception is essential for disease prevention and control. However, current methodologies lack rigorously validated instruments to assess the perceived risk of sarcopenia among this group. Thus, this study aimed to develop and validate a sarcopenia disease risk perception scale for older adults.
designThe study was conducted in two phases: development of the initial scale and its psychometric evaluation. A STROBE checklist was employed.
methodsBased on the two-factor model of risk perception theory and the health belief model, the initial draft of the scale was created through literature review, expert consultations, and a preliminary survey with a small sample. Then, we used a cross-sectional study methodology to conveniently select 438 Chinese older adults. Item analysis, exploratory factor analysis (EFA), and confirmatory factor analysis (CFA) were used to refine and validate the scale items. Internal consistency and external consistency were assessed to confirm the scale's reliability.
resultsThese evaluations established the scale's framework: content validity, item analysis, and EFA. The two factors extracted from the initial analysis explained 62.250% of the observation variance. The CFA confirmed a good fit for the model, demonstrating the scale's robust reliability and validity. The finalized scale includes 15 items and two dimensions: perceived susceptibility (eight items) and perceived severity (seven items).
conclusionThe Sarcopenia Disease Risk Perception Scale for Older Adults is reliable and valid, making it appropriate for assessing the risk perception level in the target population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.